<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We previously identified FOXF1 as a potential <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor gene with an essential role in preventing DNA rereplication to maintain genomic stability, which is frequently inactivated in <z:hpo ids='HP_0003002'>breast cancer</z:hpo> through the epigenetic mechanism </plain></SENT>
<SENT sid="1" pm="."><plain>Here we further addressed the role of the p53-p21(WAF1) checkpoint pathway in DNA rereplication induced by silencing of FOXF1 </plain></SENT>
<SENT sid="2" pm="."><plain>Knockdown of FOXF1 by small interference <z:chebi fb="40" ids="33697">RNA</z:chebi> (siRNA) rendered colorectal p53-null and p21(WAF1)-null HCT116 <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells more susceptible to rereplication and <z:mpath ids='MPATH_3'>apoptosis</z:mpath> than the <z:mp ids='MP_0002169'>wild-type</z:mp> parental cells </plain></SENT>
<SENT sid="3" pm="."><plain>In parental HCT116 cells with a functional p53 checkpoint, the p53-p21(WAF1) checkpoint pathway was activated upon FOXF1 knockdown, which was concurrent with suppression of the CDK2-Rb cascade and induction of G(1) arrest </plain></SENT>
<SENT sid="4" pm="."><plain>In contrast, these events were not observed in FOXF1-depleted HCT116-p53-/- and HCT116-p21-/- cells, indicating that the p53-dependent checkpoint function is vital for inhibiting CDK2 to induce G(1) arrest and protect cells from rereplication </plain></SENT>
<SENT sid="5" pm="."><plain>The pharmacologic inhibitor (<z:chebi fb="111" ids="27732">caffeine</z:chebi>) of <z:hpo ids='HP_0001251'>ataxia</z:hpo> <z:hpo ids='HP_0001009'>telangiectasia</z:hpo> mutated (ATM) and <z:hpo ids='HP_0001251'>ataxia</z:hpo> <z:hpo ids='HP_0001009'>telangiectasia</z:hpo> and Rad3 related (ATR) protein kinases abolished activation of the p53-p21(WAF1) pathway upon FOXF1 knockdown, suggesting that suppression of FOXF1 function triggered the ATM/ATR-mediated DNA damage response </plain></SENT>
<SENT sid="6" pm="."><plain>Cosilencing of p53 by siRNA synergistically enhanced the effect of FOXF1 <z:mpath ids='MPATH_63'>depletion</z:mpath> on the stimulation of DNA rereplication and <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in <z:mp ids='MP_0002169'>wild-type</z:mp> HCT116 </plain></SENT>
<SENT sid="7" pm="."><plain>Finally, we show that FOXF1 expression is predominantly silenced in breast and <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cell lines with inactive p53 </plain></SENT>
<SENT sid="8" pm="."><plain>Our study demonstrated that the p53-p21(WAF1) checkpoint pathway is an intrinsically protective mechanism to prevent DNA rereplication induced by silencing of FOXF1 </plain></SENT>
</text></document>